Physician profile
Princy Arora
NPI 1922030246
$3,211.93
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,076 · 2020: $646 · 2021: $791 · 2022: $171 · 2023: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $527.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $825.32 | 2019-2023 | Vns Therapy |
| Teva Pharmaceuticals USA, INC. | $740.06 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $298.43 | 2019-2020 | |
| Boston Scientific Corporation | $198.89 | 2021-2022 | |
| Eisai INC. | $167.53 | 2020-2021 | |
| Ucb, INC. | $136.05 | 2019-2021 | |
| Allergan, INC. | $131.78 | 2019-2022 | |
| Celgene Corporation | $127.02 | 2020-2022 | |
| Adamas Pharmaceuticals, INC. | $123.97 | 2019-2021 | |
| Amgen INC. | $74.47 | 2019-2020 | |
| Lilly USA, LLC | $65.24 | 2019 | |
| Sunovion Pharmaceuticals INC. | $59.45 | 2020 | |
| Abbvie INC. | $57.62 | 2021-2022 | |
| Csl Behring | $46.97 | 2019 | |
| Abbott Laboratories | $45.24 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $30.53 | 2020-2021 | |
| Kyowa Kirin, INC. | $27.84 | 2020 | |
| Amneal Pharmaceuticals LLC | $20.62 | 2019 | |
| Lundbeck LLC | $19.14 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Princy Arora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.